Cowin Venture
VC Fund
Beijing, China
Cowin Venture is a VC fund in Beijing focused on Health Care and Medical. Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
- Total investments:
- 104
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Cowin Venture invests in
Stages Cowin Venture invests in
Countries Cowin Venture invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Angel
- $425k–$1.4M
- Series A
- $1.4M–$25M
- Series B
- $2.8M–$257M
Investment Focus
Industry
- Health Care 28 (27%)
- Medical 25 (24%)
- Biotechnology 25 (24%)
- Manufacturing 12 (12%)
- Electronics 8 (8%)
Stage
- Series A 43 (41%)
- Angel 15 (14%)
- Series B 13 (13%)
- Seed 9 (9%)
- Series D 4 (4%)
Country
- China 55 (53%)
- United States 13 (13%)
- Hong Kong 2 (2%)
- Canada 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ben Zhao
Founding Managing Partner
|
Founding Managing Partner | Total investments: 0 | Find email | |
|
Cara Zhang
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies. | $14.8M / Series A / Jul 30, 2026 | ||
|
StringMotion Future
|
StringMotion Future focuses on the core technology research and development of tendon-inspired chord-driven robots, creating advanced robotic systems designed to deliver greater flexibility, precision, and efficiency for industrial and intelligent automation applications. | Angel / May 21, 2026 | |
| Diling Technology is a comprehensive, one-stop content security solution provider, specializing in the identification and management of content-related security risks. | Series A / Dec 15, 2025 | ||
| Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses. | Series A / Sep 12, 2025 | ||
|
Excalipoint Therapetics
|
Excalipoint Therapeutics is a Private limited company. | Series A / Aug 04, 2025 | |
|
Excalipoint Therapetics
|
Excalipoint Therapeutics is a Private limited company. | $41M / Seed / Aug 04, 2025 | |
| Arima Genomics is a biotechnology company that aims to accelerate the understanding of genome sequence and structure. | $22M / Series C / Jun 17, 2025 | ||
| BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine. | $27.8M / Series A / Jun 17, 2025 | ||
| Meraki is dedicated to serving the European and American markets with a curated range of products designed specifically for home coffee lovers. With a deep understanding of regional preferences and a passion for quality. | $1.4M / Angel / Apr 15, 2025 | ||
| Fluoever manufactures high-performance fluorine-containing thin film solutions. Its high-performance fluorine-containing thin film products are aimed at markets such as new energy, semiconductors, consumer electronics, and others. | Series A / Jan 20, 2025 | ||
| See all 104 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cowin Venture invest in?
Cowin Venture invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Angel stage. Most of the 104 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cowin Venture's check size?
Cowin Venture typically joins rounds of $425k–$1.4M at Angel, $1.4M–$25M at Series A and $2.8M–$257M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cowin Venture participates in.
How do I contact Cowin Venture?
Public channels for Cowin Venture include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cowin Venture?
The team at Cowin Venture includes Ben Zhao (Founding Managing Partner) and Cara Zhang (Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
